Post

ASCO24: Another win for Opdivo/Yervoy in first-line HCC despite uncertainties

At the American Society of Clinical Oncology (ASCO) Congress 2024, a first look at the clinical data from Bristol Myers …

ChromaDex wins orphan designation for rare ataxia drug

ChromaDex has announced that its treatment candidate nicotinamide riboside chloride (NRC) for the rare disease ataxia telangiectasia, has been granted …

FDA admonishes Jiangsu Hengrui’s manufacturing site following inspection

The US Food and Drug Administration (FDA) has criticised the state of Chinese pharma company Jiangsu Hengrui’s facilities in a …

Orano Med unveils radiopharma manufacturing plant in Indianapolis 

As the radiopharmaceuticals space continues to boom, it raises the challenges associated with the manufacturing and logistics of this class …

FDA AdCom to question efficacy and safety concerns with Eli Lilly’s Alzheimer’s drug

Questions about a change of primary endpoint, treatment cessation and mortality reporting will be asked by a US Food and …